Last updated on April 2019

Study to Assess the Safety and Effectiveness of Beltavac Polymerised With Alternaria Alternata

Brief description of study

Non-interventional Study to Assess the Safety and Effectiveness Profile of a SCIT Therapy With Beltavac Polymerised With Alternaria alternata in allergic patients

Detailed Study Description

This prospective open multi-centre non-interventional study assess the safety and effectiveness profile of the subcutaneous allergen-specific immunotherapy with Beltavac polimerizado in Alternaria alternata allergic patients (children and adults) in routine medical care.

Patients receive a rush schedule administration every month for a year. They attend at least 4 study visits to inform about the adverse reactions, the self reported symptoms and the medication intake.

Clinical Study Identifier: NCT03604718

Find a site near you

Start Over

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.